Oxford Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,539	Closed	-$252K	–	2003
2018 Q4	$252K	Buy	5,539 +2,913	+111%	+$133K	0.01%	1464
2018 Q3	$218K	Buy	+2,626	New	+$218K	﹤0.01%	1578
2018 Q1	–	Sell	-2,052	Closed	-$321K	–	1904
2017 Q4	$321K	Buy	+2,052	New	+$321K	0.01%	1317